Medicare Enrolled
Dr. Rajesh Chawla, M.D.
Cardiovascular Disease · Arcadia, CA
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Chawla from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Chawla?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Chawla
Dr. Rajesh Chawla is a cardiovascular disease specialist in Arcadia, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Chawla performed 5,268 Medicare services across 3,280 unique beneficiaries.
Between the years covered by Open Payments, Dr. Chawla received a total of $9,069 from 32 pharmaceutical and/or device companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Chawla is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 18% volume in CA
$9,069 industry payments
Medicare Practice Summary
Medicare Utilization ↗5,268
Medicare services
Top 18% in CA for cardiovascular disease
3,280
Unique beneficiaries
$244
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~277 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
779 | $73 | $155 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
737 | $93 | $225 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
644 | $44 | $125 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
636 | $7 | $10 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
335 | $169 | $700 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
237 | $66 | $135 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
188 | $95 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
178 | $58 | $200 |
| Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | 162 | $408 | $600 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
128 | $216 | $600 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
119 | $22 | $75 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
100 | $12 | $65 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
94 | $404 | $1,600 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
90 | $129 | $300 |
| Nuclear stress test with CT scan A nuclear medicine imaging test that evaluates blood flow in the heart muscle at rest and during stress, performed alongside a concurrent CT scan. |
81 | $1,701 | $2,700 |
| PET scan of heart muscle blood flow A nuclear medicine imaging test that uses positron emission tomography (PET) to evaluate blood flow within the heart muscle. |
81 | $122 | $250 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
73 | $157 | $550 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
70 | $106 | $275 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
67 | $63 | $120 |
| Hospital follow-up visit, low complexity Follow-up hospital visit for an established patient with straightforward or low-level medical decision making. The visit requires at least 25 minutes of time spent on the day of service. |
59 | $41 | $95 |
| Arterial plaque removal in leg A procedure to remove plaque buildup from the arteries in the leg to restore blood flow. |
58 | $7,309 | $31,590 |
| Continuous EKG monitoring review, 48-7 days Review and interpretation of continuous external EKG recordings lasting more than 48 hours up to 7 days. |
52 | $19 | $50 |
| Continuous external EKG monitoring, 48 hours to 7 days This procedure involves recording the heart's electrical activity continuously using an external device for a period exceeding 48 hours but not more than 7 days. |
51 | $10 | $50 |
| 2-day continuous ECG monitoring A continuous electrocardiogram recording that captures heart activity over a 48-hour period. This test helps detect irregular heart rhythms or other cardiac issues that may not appear during a standard, short-term ECG. |
47 | $15 | $50 |
| 2-day continuous ECG with professional review A two-day continuous electrocardiogram recording that includes a review by a healthcare professional. |
47 | $14 | $50 |
| Ultrasound of arm or leg veins An ultrasound exam of the veins in the arm or leg. The test uses sound waves to check blood flow and may include compression and other maneuvers. |
40 | $160 | $500 |
| Arterial plaque removal, initial vessel A procedure to remove plaque buildup from an artery in the leg. This is performed on the first vessel treated during the session. |
29 | $8,347 | $32,059 |
| Radiologist review of arm or leg artery images A radiologist reviews images of the arteries in one or both arms or legs to assess blood flow and vessel health. |
29 | $143 | $547 |
| Cardiac catheterization | 22 | $204 | $950 |
| Arterial plaque removal, each additional leg vessel This procedure involves the removal of plaque buildup from an additional artery in the leg during the same session. It is performed to restore blood flow in the treated vessel. |
19 | $947 | $3,626 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
16 | $134 | $275 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
10.3% high complexity
27.1% medium
62.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,069
Total received (2018-2024)
Avg $1,296/year across 7 years
Top 29% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
32
Companies
399
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,763 (96.6%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$277 (3.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28 (0.3%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,245
2023
$1,367
2022
$1,272
2021
$1,385
2020
$1,234
2019
$1,330
2018
$1,236
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Medtronic, Inc.
$335
Merck Sharp & Dohme LLC
$188
Amgen Inc.
$125
SANOFI-AVENTIS U.S. LLC
$85
United Therapeutics Corporation
$81
Bayer Healthcare Pharmaceuticals Inc.
$72
Novartis Pharmaceuticals Corporation
$67
Actelion Pharmaceuticals US, Inc.
$53
PFIZER INC.
$50
Boston Scientific Corporation
$45
Lexicon Pharmaceuticals, Inc.
$40
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$30
Boehringer Ingelheim Pharmaceuticals, Inc.
$21
Novo Nordisk Inc
$20
Abbott Laboratories
$19
Celgene Corporation
$15
Top 3 companies account for 52.1% of 2024 payments
All-time payments by company (2018-2024) ›
Medtronic, Inc.
$1,082
Cardiovascular Systems Inc.
$675
Novartis Pharmaceuticals Corporation
$630
AstraZeneca Pharmaceuticals LP
$528
Abbott Laboratories
$492
Amgen Inc.
$486
Esperion Therapeutics, Inc.
$482
Actelion Pharmaceuticals US, Inc.
$469
SANOFI-AVENTIS U.S. LLC
$402
Bayer HealthCare Pharmaceuticals Inc.
$388
Bayer Healthcare Pharmaceuticals Inc.
$349
Janssen Pharmaceuticals, Inc
$347
PFIZER INC.
$341
Boston Scientific Corporation
$336
Medtronic Vascular, Inc.
$324
United Therapeutics Corporation
$301
Boehringer Ingelheim Pharmaceuticals, Inc.
$220
E.R. Squibb & Sons, L.L.C.
$216
Merck Sharp & Dohme LLC
$211
Gilead Sciences, Inc.
$140
Amarin Pharma Inc.
$119
BOSTON SCIENTIFIC CORPORATION
$104
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$88
Lexicon Pharmaceuticals, Inc.
$80
Lundbeck LLC
$60
ARBOR PHARMACEUTICALS, INC.
$57
Lilly USA, LLC
$37
Arbor Pharmaceuticals, Inc.
$36
Novo Nordisk Inc
$20
Kowa Pharmaceuticals America, Inc.
$18
Cardinal Health 200 LLC
$17
Celgene Corporation
$15
Top 3 companies account for 26.3% of all-time payments
Associated products mentioned in payments ›
ACCOLADE · ACCOLADE SR · Adempas · BRILINTA · BodyGuardian · CAMZYOS · CHANTIX · COREVALVE EVOLUT R · CardioMEMS HF System · Cobalt · Confirm Rx · Corlanor · DIAMONDBACK PERIPHERAL · Diamondback Peripheral · ELIQUIS · EMBLEM · EMGALITY · ENTRESTO · Edarbi · Edarbyclor · FARXIGA · Inpefa · JARDIANCE · JOT DX · KRYSTEXXA · Kerendia · LEQVIO · LINQ II · LIVALO · LUX DX · LUX-DX · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MULTAQ · Micra · MyCareLink · NEXLETOL · NORTHERA · OPSUMIT · OPSUMIT MACITENTAN · ORENITRAM · Ozempic · PERCLOSE PROGLIDE · PRADAXA · PRALUENT · PRECISE PRO RX Carotid Stent System · Peripheral Orbital Atherectomy System · Quadra Allure MP RF CRT Pacemkr · RESONATE · Ranexa · Repatha · SELECTSECURE · TRULICITY · TYVASO · UPTRAVI · VERQUVO · Vascepa · Verquvo · WINREVAIR · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (97%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
510
Per 100K population
5.2
County median income
$87,760
Nearest hospital
USC ARCADIA HOSPITAL
1.3 mi
1.3 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Chawla is a clinical cardiology specialist, with above-average Medicare volume (top 18% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Chawla experienced with office visit, established patient (20-29 min)?
Based on Medicare claims data, Dr. Chawla performed 779 office visit, established patient (20-29 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Chawla receive payments from pharmaceutical companies?
Yes. Dr. Chawla received a total of $9,069 from 32 companies across 399 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Chawla's costs compare to other cardiologists in Arcadia?
Dr. Chawla's average Medicare payment per service is $244. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Chawla) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Arcadia
Browse cardiologists in Arcadia ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
Medtronic, Inc. Payments to Doctors
See all physicians who received payments from Medtronic, Inc.
By company
Cardiovascular Systems Inc. Payments to Doctors
See all physicians who received payments from Cardiovascular Systems Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology